Atomera (ATOM) Q4 2016 earnings summary

Executive summary

• Development-stage licensing strategy centers on MST, a silicon thin-film technology intended to improve transistor speed, reliability and energy efficiency without major manufacturing changes.

• 2016 brought an IPO, expanded customer engagement and faster internal development cycles; commercial adoption and revenue generation remain unproven.

Financial highlights

• Revenue-producing operations had not begun; operating expenses were $10.0M in 2016 vs. $5.5M in 2015.

• Net loss was $12.61M in 2016 vs. $9.51M in 2015; R&D expense rose to $4.0M from $2.0M, primarily reflecting customer evaluation work and engineering headcount.

• 2016 G&A was $5.1M vs. $3.4M, reflecting compensation, IPO-related awards and relocation costs, partly offset by lower professional fees.

Outlook and guidance

• Available working capital was expected to fund the current plan for at least 12 months from the March 2017 filing, including customer qualification and efforts to reach full-scale production.

• Management expected 2017 G&A and selling and marketing expense to increase; engineering headcount was expected to remain at or above 2016 levels.

• Customer qualification and licensing may take 18–36 months or longer; the near-term priority was securing a licensee and enabling commercial-scale production.